Follow-The-Filings

Security · featured owners

PGEN Precigen Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 3.6%
  • $109M
  • 1 add 1 exit

PGEN (Precigen Inc.) is held in 1 featured 13F book as of 2026 Q2. Samantha Mclemore - Patient Capital Management is the largest tracked holder by portfolio weight (3.6%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 3.6% (Samantha Mclemore - Patient Capital Management) · not free-float ownership

  1. Samantha Mclemore Add 3.6%

Holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

History
Samantha Mclemore - Patient Capital Management 2026 Q2 3.6% Add +6.8% 19,036,976 $109M History
Farallon Capital Management exited 2026 Q2 Last 2026 Q1 <0.01% Exit 0.00% 50,000 $194K History

1 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 8 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02 Filing Doc
10-Q Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
DEFA14A Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 13 rows shown

Filed Form Detail Links
4 Period Sep 23, 2026 Filing Doc
4 Period Aug 26, 2026 Filing Doc
4 Period Aug 23, 2026 · 2 forms Filing Doc
4 Period Aug 21, 2026 Filing Doc
4 Period Aug 23, 2026 · 2 forms Filing Doc
4 Period Aug 21, 2026 Filing Doc
4 Period Aug 6, 2026 Filing Doc
4 Period Aug 3, 2026 Filing Doc
4 Period Jul 31, 2026 Filing Doc
4 Period Jun 29, 2026 · 3 forms Filing Doc
4 Period May 28, 2026 · 5 forms Filing Doc
4 Period May 23, 2026 · 5 forms Filing Doc
4 Period Apr 20, 2026 Filing Doc

Updated 6 days ago Source: SEC EDGAR submissions All on EDGAR

Financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue — — $9.68M
Net income -$95.9M -$126.24M -$250.64M
Net margin * — — -2588.2%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $68.76M $102.41M $115.24M
Total non-current assets * $82.29M $42.85M $40.27M
Total assets $151.04M $145.27M $155.5M
Total current liabilities $22.98M $21.52M $37.31M
Total non-current liabilities * $9.56M $57.02M $97.29M
Total equity $118.5M $38.51M $20.91M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$66.93M -$68.17M -$87.83M
Cash from investing -$3.09M -$20.71M -$1.54M
Cash from financing $29.59M $110.58M $90.05M
Net change in cash -$40.75M $21.67M $0.717M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

Ownership over time

filing count by report period · click a bar for that quarter’s holders